Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cartesian Therapeutics (RNAC) Tax Rate: 2021-2022

  • Cartesian Therapeutics' Tax Rate was N/A to 3.91% in Q3 2022 from the same period last year, while for Dec 2022 it was 73.75%, marking a year-over-year change of. This contributed to the annual value of 7.96% for FY2023, which is N/A change from last year.
  • As of Q3 2022, Cartesian Therapeutics' Tax Rate stood at 3.91%, which was up 250.50% from 1.11% recorded in Q4 2021.
  • Cartesian Therapeutics' 5-year Tax Rate high stood at 3.91% for Q3 2022, and its period low was 1.11% during Q4 2021.
  • Its 2-year average for Tax Rate is 2.51%, with a median of 2.51% in 2021.